Page last updated: 2024-08-17

ficusin and Carcinoma, Basal Cell, Pigmented

ficusin has been researched along with Carcinoma, Basal Cell, Pigmented in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (25.00)	18.2507
2000's	5 (62.50)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abeni, D; Didona, B; Paradisi, A; Russo, N; Sobrino, L; Tabolli, S	1
Lim, JL; Stern, RS	1
Heitzer, E; Wolf, P	1
Liebman, EJ; Stern, RS; Väkevä, L	1
Dybdahl, M; Frentz, G; Nexø, BA; Vogel, U; Wallin, H	1
Bäck, B; Höfler, G; Kerl, H; Kreimer-Erlacher, H; Seidl, H; Soyer, HP; Wolf, P	1
Katz, KA; Marcil, I; Stern, RS	1
Bagheri, S; Nichols, K; Stern, RS	1

Trials

2 trial(s) available for ficusin and Carcinoma, Basal Cell, Pigmented

Article	Year
Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. Journal of the National Cancer Institute, 1998, Sep-02, Volume: 90, Issue:17 Topics: Administration, Oral; Adult; Analysis of Variance; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Ficusin; Follow-Up Studies; Humans; Male; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Psoriasis; Risk Factors; Skin Neoplasms; Ultraviolet Rays	1998
Low DNA repair is a risk factor in skin carcinogenesis: a study of basal cell carcinoma in psoriasis patients. Mutation research, 1999, Jan-26, Volume: 433, Issue:1 Topics: Adult; Age Factors; Carcinoma, Basal Cell; Denmark; DNA Repair; DNA, Neoplasm; Female; Ficusin; Humans; Lymphocytes; Male; Middle Aged; Psoriasis; Risk Factors; Skin Neoplasms; Statistics, Nonparametric; Transfection; Tumor Cells, Cultured; Ultraviolet Therapy	1999

Article

Year

Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.

Journal of the National Cancer Institute, 1998, Sep-02, Volume: 90, Issue:17

Topics: Administration, Oral; Adult; Analysis of Variance; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Ficusin; Follow-Up Studies; Humans; Male; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Psoriasis; Risk Factors; Skin Neoplasms; Ultraviolet Rays

1998

Low DNA repair is a risk factor in skin carcinogenesis: a study of basal cell carcinoma in psoriasis patients.

Mutation research, 1999, Jan-26, Volume: 433, Issue:1

Topics: Adult; Age Factors; Carcinoma, Basal Cell; Denmark; DNA Repair; DNA, Neoplasm; Female; Ficusin; Humans; Lymphocytes; Male; Middle Aged; Psoriasis; Risk Factors; Skin Neoplasms; Statistics, Nonparametric; Transfection; Tumor Cells, Cultured; Ultraviolet Therapy

1999

Other Studies

6 other study(ies) available for ficusin and Carcinoma, Basal Cell, Pigmented

Article	Year
Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:6 Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Female; Ficusin; Humans; Incidence; Logistic Models; Male; Melanoma; Middle Aged; Multivariate Analysis; Photosensitizing Agents; Risk; Risk Factors; Skin Neoplasms; Ultraviolet Therapy; Vitiligo	2014
High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. The Journal of investigative dermatology, 2005, Volume: 124, Issue:3 Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Environmental Exposure; Female; Ficusin; Follow-Up Studies; Humans; Incidence; Male; Photosensitizing Agents; Psoriasis; Risk Factors; Skin Neoplasms; Ultraviolet Rays	2005
Nonmonoclonal PTCH gene mutations in psoralen plus UVA-associated basal cell carcinomas. The Journal of investigative dermatology, 2008, Volume: 128, Issue:3 Topics: Carcinoma, Basal Cell; Ficusin; Humans; Mutation; Patched Receptors; Patched-1 Receptor; Photosensitizing Agents; Prevalence; Receptors, Cell Surface; Skin Neoplasms; Ultraviolet Rays	2008
Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis. The Journal of investigative dermatology, 2001, Volume: 117, Issue:2 Topics: Adult; Aged; Carcinoma, Basal Cell; Female; Ficusin; Humans; Incidence; Male; Middle Aged; Photosensitizing Agents; Point Mutation; Polymorphism, Single-Stranded Conformational; Psoriasis; PUVA Therapy; Skin Neoplasms; Tumor Suppressor Protein p53; Ultraviolet Rays	2001
Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients. The Journal of investigative dermatology, 2002, Volume: 118, Issue:6 Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Female; Ficusin; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Neoplasms, Second Primary; Photosensitizing Agents; Psoriasis; Risk Factors; Skin Neoplasms; Survival Analysis; Ultraviolet Rays	2002
The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:1 Topics: Adult; Age Distribution; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Ficusin; Genital Neoplasms, Male; Genitalia, Male; Humans; Incidence; Male; Middle Aged; Probability; Prognosis; Prospective Studies; Psoriasis; PUVA Therapy; Risk Factors; Skin Neoplasms	2002